Microcarriers Market Share, Size, Trends, Industry Analysis Report, By Product (Consumables, Equipment); By Application; By Therapy; By Region; Segment Forecast, 2024 - 2032

Microcarriers Market Share, Size, Trends, Industry Analysis Report, By Product (Consumables, Equipment); By Application; By Therapy; By Region; Segment Forecast, 2024 - 2032

The global microcarriers market size is expected to reach USD 4.11 billion by 2032, according to a new study by Polaris Market Research. The report “Microcarriers Market Share, Size, Trends, Industry Analysis Report, By Product (Consumables, Equipment); By Application; By Therapy; By Region; Segment Forecast, 2024 - 2032” gives a detailed insight into current market dynamics and provides analysis on future market growth.

Microcarriers are gaining traction nowadays, with increased research activities exploring potential benefits in the healthcare sector. The ability to adjust its therapeutic properties according to diverse needs is one of the major factors driving its use as an alternative to regenerative medicine and drug delivery. They can carry drugs, peptides, and other therapeutic compounds, which is grabbing attention in the pharmaceutical space. They are widely employed in regenerative research activities as they are prominent in cell manufacturing and drug carrier tasks.

Healthcare researchers are increasing their focus on cell therapy with a view to creating treatments for existing health issues, such as cancer, urinary problems, autoimmune diseases, repairing damaged cartilage in joints, and more. This will necessitate the need for microcarriers due to their potential to carry extracellular matrix proteins and peptides. In cell manufacturing, microcarriers are used to culture large amounts of cells in small volumes, enhancing surface attachment.

The growing development of microcarriers with advanced capabilities is boosting the growth of the microcarrier industry. For instance, in November 2023, Teijin Frontier introduced non-oven microcarriers for cell culture. They enable speedy, large-scale, high-quality cell culture.

The rising research innovations, along with the new product launches in the marketplace, are expected to boost the applications of microcarriers. For instance, in October 2023, Kuraray Co. announced the development of PVA hydrogel microcarriers in regenerative medicine for cell cultures, which is likely to launch in 2024.

Companies are working to drive advancements in bio-sustainability with cell-cultured meat production and expand their research centers to meet their objectives. Notably, in 2023, Cytoniche Biotechnology unveiled its new Centre of Excellence, a research and development center in China. In the same year, Matrix F.T. introduced an initially cultivated chicken made up of its edible microcarriers.

Microcarriers Market Report Highlights

The consumables segment is anticipated to witness the highest growth in the coming years due to the need for cell expansion.

Biopharmaceutical Production segment accounts for the largest market share owing to its capacity to produce a higher volume of cells.

Cell & Gene Therapy segment is projected to experience a larger revenue share due to the need for cell manufacturing.

Asia Pacific is projected to have the fastest growth during the study period owing to the increasing investments in cell and gene therapy.

The global players include bbi-biotech GmbH, Bionet, ChemoMetec, Corning Incorporated, Danaher Corporation, Distek, Inc., Entegris & Eppendorf SE.

Polaris Market Research has segmented the microcarriers market report based on product, application, therapy, and region:

Microcarriers, Product Outlook (Revenue - USD Billion, 2019 - 2032)

Consumables

Equipment

Microcarriers, Application Outlook (Revenue - USD Billion, 2019 - 2032)

Biopharmaceutical Production

Tissue Engineering and Regenerative Medicine

Other Applications

Microcarriers, Therapy Outlook (Revenue - USD Billion, 2019 - 2032)

Cell & Gene Therapy

Other tissue engineering and regenerative medicine Applications

Microcarriers, Regional Outlook (Revenue - USD Billion, 2019 - 2032)

North America

U.S.

Canada

Europe

Germany

UK

France

Italy

Spain

Russia

Netherlands

Asia Pacific

China

India

Japan

South Korea

Indonesia

Malaysia

Latin America

Argentina

Brazil

Mexico

Middle East & Africa

UAE

Saudi Arabia

Israel

South Africa